Are quantitative functional measures more sensitive to worsening MS than traditional measures?
- 26 December 2000
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 55 (12), 1901-1903
- https://doi.org/10.1212/wnl.55.12.1901
Abstract
Article abstract The authors used data collected prospectively during a multicenter trial in 133 patients with secondary progressive MS to assess the relative sensitivity of quantitative functional tests and traditional measures, including the Expanded Disability Status Scale (EDSS) and Ambulation Index. Quantitative functional measures worsened in 69% of patients during an average of 6 months of observation, whereas the Clinical Global Impression of Change worsened in 33% and the EDSS worsened in 25% of patients. These changes should be interpreted in the context of the test–retest reliability for each measure.Keywords
This publication has 10 references indexed in Scilit:
- Linomide in relapsing and secondary progressive MSNeurology, 2000
- Linomide in relapsing and secondary progressive MSNeurology, 2000
- A profile of multiple sclerosis: The New York State Multiple Sclerosis ConsortiumMultiple Sclerosis Journal, 1999
- Development of a multiple sclerosis functional composite as a clinical trial outcome measureBrain, 1999
- Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trialsMultiple Sclerosis Journal, 1998
- The measurement of ambulatory impairment in multiple sclerosisNeurology, 1997
- Recommendations from the national multiple sclerosis society clinical outcomes assessment task forceAnnals of Neurology, 1997
- Clinical outcomes assessment in multiple sclerosisAnnals of Neurology, 1996
- Outcomes assessment in multiple sclerosis clinical trials: a critical analysisMultiple Sclerosis Journal, 1995
- Inter‐ and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS)Neurology, 1992